Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.07. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
20.06. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
13.06. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
14.05. | PROVECTUS BIOPHARMACEUTICALS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
29.04. | PROVECTUS BIOPHARMACEUTICALS, INC. - 10-K/A, Annual Report | 1 | SEC Filings | ||
16.04. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
28.03. | PROVECTUS BIOPHARMACEUTICALS, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
27.03. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium | 86 | GlobeNewswire (Europe) | New Provectus Spinout Company Would Commercialize Combination Therapy of University's Light Source Medical Device and Provectus's Pharmaceutical-Grade Rose Bengal Sodium KNOXVILLE, TN, March 27,... ► Artikel lesen | |
26.03. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
12.03. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines | 265 | GlobeNewswire (Europe) | KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company") (OTCQB: PVCT) today announced that the United States Patent and Trademark Office... ► Artikel lesen | |
22.02. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | 3 | SEC Filings | ||
15.02. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
15.02. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call | 3 | GlobeNewswire (USA) | ||
18.12.23 | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant | 211 | GlobeNewswire (Europe) | KNOXVILLE, TN, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed patent application 17/488,430, titled... ► Artikel lesen | |
15.11.23 | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous Melanoma | 374 | GlobeNewswire (Europe) | KNOXVILLE, TN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1b/2 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal... ► Artikel lesen | |
13.11.23 | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma | 602 | GlobeNewswire (Europe) | KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 116,52 | -0,14 % | Diese Aktie schlägt Novo Nordisk um Längen | Für die Medikamente von Novo Nordisk gegen Fettleibigkeit (Adipositas) und Diabetes werden immer neue Anwendungsgebiete gefunden: Die Bestseller Ozempic und Wegovy verkaufen sich wie warme Semmeln -... ► Artikel lesen | |
AURORA CANNABIS | 5,410 | -0,55 % | Vor den Zahlen: Bahnt sich bei Canopy Growth, Aurora Cannabis & Co. die Trendwende an? | © Foto: adobe.stock.comDie US-Wahlen werfen ihre Schatten voraus. Auch im Cannabis-Sektor verfolgt man die aktuellen Entwicklungen mit Argusaugen. Zuletzt ließ eine Meldung die Kurse von Canopy Growth... ► Artikel lesen | |
CANOPY GROWTH | 6,750 | +0,45 % | Stocks in Play: Canopy Growth Corporation | ||
TILRAY BRANDS | 1,681 | -0,53 % | Tilray Brands, Inc.: Tilray erhält erste neue Cannabis-Anbaulizenz in Deutschland nach neuen Vorschriften | Aphria RX-Anlage von Tilray in Deutschland erhält neue Cannabis-Anbaulizenz, die eine ca. 5-fache Produktionssteigerung und neue Sorten ermöglicht, um den Zugang für Patienten im ganzen Land zu verbessern
Aphria... ► Artikel lesen | |
VERTEX PHARMACEUTICALS | 458,75 | +0,54 % | Is Vertex Pharmaceuticals' Monopoly in Danger? | ||
TAAT GLOBAL ALTERNATIVES | 0,118 | -22,11 % | TAAT Global Alternatives Inc (2): SEC defendant Alomari protests TAAT charges | ||
CRONOS GROUP | 2,202 | -1,43 % | Cronos Group Inc: Cronos to hold Q2 results call Aug. 8 | ||
DIGICANN VENTURES | 0,005 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures | ||
SANOCHEMIA PHARMAZEUTIKA | - | - | Nachlese: Magnus Brunner vs. FMA" EOSS holt nach Sanochemia auch BDI BioEnergy; Bettina Pfluger (Christian Drastil) | Um 12:12 liegt der ATX mit +0.03 Prozent im Plus bei 3452 Punkten (Ultimo 2023: 3435, 0.49% ytd). Topperformer der PIR-Group sind Addiko Bank mit +1.82% auf 15.425 Euro, dahinter DO&CO mit +1.79% auf... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | +100,00 % | WPD Pharmaceuticals Inc: WPD to settle debt with shares | ||
ORGANIGRAM | 1,494 | -0,13 % | ORGANIGRAM HOLDINGS INC. - 6-K, Report of foreign issuer | ||
GREEN THUMB INDUSTRIES | 10,260 | +0,79 % | Green Thumb Industries Inc: Green Thumb Industries expands Beboe brand to New York | ||
MYDECINE INNOVATIONS GROUP | 0,010 | 0,00 % | Mydecine Innovations Group Inc - Annual and Q1 Financial Statements | Mydecine Innovations Group Inc - Annual and Q1 Financial Statements
PR Newswire
LONDON, United Kingdom, July 08
MYDECINE ANNOUCES FILING OF AUDITED AND Q1 FINANCIAL STATEMENTSVancouver... ► Artikel lesen | |
SINOPHARM | 2,168 | -1,45 % | Minimaler Kursabschlag bei der Sinopharm Group-Aktie (2,20 €) | Der Kurs der dem Anteilsschein der Sinopharm Group kommt kaum von der Stelle. Der jüngste Kurs betrug 2,20 Euro. Jahreschart der Sinopharm Group Ltd.-Aktie, Stand 19.07.2024 Einen geringen Preisabschlag... ► Artikel lesen | |
INDIVA | 0,016 | 0,00 % | XFRA T8RP: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILINDIVA LTD T8RP... ► Artikel lesen |